Vontobel Holding’s Actinium Pharmaceuticals ATNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56K Hold
50,000
– – ﹤0.01% 1457
2026
Q2
$49K Buy
50,000
+20,000
+67% +$23.1K ﹤0.01% 1449
2026
Q1
$29.9K Hold
30,000
– – ﹤0.01% 1181
2025
Q4
$40.8K Hold
30,000
– – ﹤0.01% 1411
2025
Q3
$48K Hold
30,000
– – ﹤0.01% 1327
2025
Q2
$42K Hold
30,000
– – ﹤0.01% 1239
2025
Q1
$48.3K Buy
30,000
+5,000
+20% +$6.35K ﹤0.01% 1061
2024
Q4
$31.5K Buy
+25,000
New +$38.8K ﹤0.01% 1085

Other funds holding ATNM

Vontobel Holding's ATNM Position: Q3 2026 in Review

Vontobel Holding held its Actinium Pharmaceuticals (ATNM) position steady in Q3 2026 at 50,000 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #1457.

Vontobel Holding first reported a position in ATNM in Q4 2024 and has held it in 8 quarters since. 50 funds tracked by Wall St. Rank hold ATNM as of Q3 2026.

  • Vontobel Holding held 50,000 shares of Actinium Pharmaceuticals worth $56K as of Q3 2026.
  • Vontobel Holding left its Actinium Pharmaceuticals share count unchanged in Q3 2026.
  • Actinium Pharmaceuticals made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #1457 holding.
  • Vontobel Holding first reported a position in Actinium Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • 50 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.